The Lactose Intolerance Treatment Market is chiefly driven by rise in awareness and greater screening rates in the world and especially in the developed regions of North America and Europe. The exact number of people with lactose intolerance is unknown but it is estimated that about 65% of the global population suffers from lactate intolerance. Considering all these factors the market for lactose intolerance treatment is expected to reach $ 9.4 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 7.2 % during 2017-2023.
Global Lactose Intolerance Treatment Market – Key Players
Key players profiled in the report are Johnson & Johnson Inc., National Enzyme Company, Vetbiochem India Private Limited, Scimera Partners, Ganeden Biotech, Daiya Foods Inc., Arla Foods, McNeil Nutritionals, Oberland-Milchverwertung (OMIRA), Parmalat, Valio and others.
Global Lactose Intolerance Treatment Market – Study Objectives
- To provide a detailed analysis of the market structure along with estimated future growth forecast for the next six years about various segments and sub-segments of the global lactose intolerance treatment market
- To provide insights about factors affecting the market growth
- To analyze the global lactose intolerance treatment market based on various factors – Price Analysis, Supply Chain Analysis, Porters Five Force analysis etc.
- To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries – the Americas, Europe, Asia Pacific along with Middle East & Africa
Global Lactose Intolerance Treatment Market – Overview
Lactose intolerance can also be managed by consuming live yogurt cultures containing lactobacilli and other milk fermentation products which explains why many people, though genetically lactose intolerant, are able to tolerate large quantities of milk. Plant-based milks such as soy milk, rice milk, coconut milk, oat milk, etc. are inherently lactose-free. Low-lactose or lactose-free versions of foods supplements are used for those patients who have high lactose intolerance. Patients with little or no lactase enzyme can be supplemented by artificially produced from microbes of genus Aspergillus. The enzyme, β-galactosidase, is used and is available over the counter in many countries.
Click to Get Sample Report @ https://www.marketresearchfuture.com/sample_request/3868 .
Lactose intolerance cause symptoms such as abdominal pain, bloating, diarrhoea, gas, nausea etc. due to the decreased ability to digest the sugar lactose in milk products. Lactose intolerance is caused due to the lack of enzyme lactase which breaks lactose into glucose and galactose. Primary lactose intolerance is due to fall in the amount of lactase due to age while secondary lactose intolerance is due to injury to the small intestine such as infections, celiac disease, inflammatory bowel disease etc. Congenital lactose intolerance is caused by genetic factors. The falling prices of lactose free foods due to rising scalability and larger sales will also stimulate the market. The non-serious nature of the symptoms of lactose intolerance is a major constraint on the market.
Global Lactose Intolerance Treatment Market – Segmentation
The global lactose intolerance treatment market is segmented on the basis of type, treatment and end users. Based on type, the market has been segmented as primary, secondary, developmental and congenital. Based on the treatment, the market has been segmented as food supplements (dairy, milk substitutes (soy, rice, coconut, almond, others), cereals and breads, fats, others), enzymatic lactase supplements, and others. Based on the end users, the market has been segmented as hospitals and clinics, home use, and others.
Global Lactose Intolerance Treatment Market – Regional Analysis
US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. The faster market uptake of new technology in the US is also an important driver of the market for global lactose intolerance treatment. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is expected to have the most potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions and poor healthcare penetration.
Get Unbelievable Discount on Report @ https://www.marketresearchfuture.com/enquiry/3868 .
Some of Major Table of Contents for “Lactose Intolerance Treatment Market Research Report- Global Forecast till 2023”
Major Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/3868 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312